PERCEPTIVE ADVISORS LLC 13D/13G Filings for BridgeBio Pharma, Inc. (BBIO)

PERCEPTIVE ADVISORS LLC 13D and 13G filings for BridgeBio Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
9:01 pm
Purchase		 2021-12-31 13G BridgeBio Pharma, Inc.
BBIO		 PERCEPTIVE ADVISORS LLC 7,128,755
4.800%		 422,487increase
(+6.30%)		 Filing
2021-02-16
3:36 pm
Unchanged		 2020-12-31 13G BridgeBio Pharma, Inc.
BBIO		 PERCEPTIVE ADVISORS LLC 6,706,268
5.500%		 0
(Unchanged)		 Filing